Key Statistics for STAA
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for STAA
- Net Income (M/USD)
STAAR Surgical Company develops, manufactures, and markets high margin visual implants that improve a patient's quality of vision. The Company manufactures implantable contact lenses to treat refractive disorders such as myopia. STAAR also manufactures products for cataract surgery and glaucoma surgery.
More Company Profile & Key Executives for STAA
|Barry Gale CaldwellPresident/CEO||Donald J Todd "Don" President:Asia Pacific|
|Hans-Martin BlickensdoerferPresident:Europe||Deborah AndrewsVP/Chief Acctg Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.